18/120
0.8 / 5 stars
All 120 Win/Lose results shown below
SHC Roast Me summary
Sotera Health Co (SHC). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinSHC / S&P 23.78% / 15.20% |
LoseSHC / S&P 8.15% / 15.00% |
WinSHC / S&P 533.33% / 50.40% |
| 2026-Q11/3 |
LoseSHC / S&P -18.71% / -4.33% |
LoseSHC / S&P 7.44% / 11.30% |
WinSHC / S&P 355.56% / 27.70% |
| 2025-Q42/3 |
WinSHC / S&P 12.14% / 2.65% |
LoseSHC / S&P 5.74% / 9.00% |
WinSHC / S&P 68.75% / 13.40% |
| 2025-Q31/3 |
WinSHC / S&P 41.46% / 8.12% |
LoseSHC / S&P 2.67% / 4.61% |
LoseSHC / S&P -20.00% / 13.45% |
| 2025-Q20/3 |
LoseSHC / S&P -4.63% / 10.94% |
LoseSHC / S&P 2.40% / 4.83% |
LoseSHC / S&P -35.71% / 10.63% |
| 2025-Q10/3 |
LoseSHC / S&P -14.77% / -4.27% |
LoseSHC / S&P 2.78% / 4.98% |
LoseSHC / S&P -52.63% / 10.57% |
| 2024-Q40/3 |
LoseSHC / S&P -18.08% / 2.41% |
LoseSHC / S&P 4.88% / 5.25% |
LoseSHC / S&P -11.11% / 6.15% |
| 2024-Q32/3 |
WinSHC / S&P 40.69% / 5.89% |
WinSHC / S&P 13.11% / 5.89% |
LoseSHC / S&P SHC unavailable / 6.11% |
| 2024-Q21/3 |
LoseSHC / S&P -1.17% / 4.28% |
WinSHC / S&P 12.50% / 5.38% |
LoseSHC / S&P SHC unavailable / 5.12% |
| 2024-Q11/3 |
LoseSHC / S&P -28.72% / 10.56% |
WinSHC / S&P 9.05% / 5.71% |
LoseSHC / S&P SHC unavailable / 5.59% |
| 2023-Q41/3 |
WinSHC / S&P 12.48% / 11.69% |
LoseSHC / S&P 4.54% / 6.81% |
LoseSHC / S&P SHC unavailable / 7.78% |
| 2023-Q30/3 |
LoseSHC / S&P -20.49% / -3.27% |
LoseSHC / S&P -0.27% / 7.52% |
LoseSHC / S&P -355.81% / -5.03% |
| 2023-Q20/3 |
LoseSHC / S&P 5.19% / 8.74% |
LoseSHC / S&P 0.55% / 9.50% |
LoseSHC / S&P -318.18% / -8.57% |
| 2023-Q11/3 |
WinSHC / S&P 115.01% / 7.50% |
LoseSHC / S&P 3.29% / 10.77% |
LoseSHC / S&P -293.75% / -15.69% |
| 2022-Q41/3 |
WinSHC / S&P 22.14% / 7.56% |
LoseSHC / S&P 7.75% / 11.88% |
LoseSHC / S&P -302.44% / -17.99% |
| 2022-Q31/3 |
LoseSHC / S&P -65.19% / -4.88% |
LoseSHC / S&P 9.51% / 13.47% |
WinSHC / S&P 290.91% / -1.41% |
| 2022-Q22/3 |
WinSHC / S&P -9.56% / -16.10% |
LoseSHC / S&P 10.20% / 13.71% |
WinSHC / S&P 4300.00% / 11.04% |
| 2022-Q10/3 |
LoseSHC / S&P -8.03% / -4.60% |
LoseSHC / S&P 13.53% / 15.97% |
LoseSHC / S&P SHC unavailable / 42.23% |
| 2021-Q40/3 |
LoseSHC / S&P -9.94% / 11.03% |
LoseSHC / S&P 13.85% / 15.00% |
LoseSHC / S&P SHC unavailable / 96.40% |
| 2021-Q31/3 |
WinSHC / S&P 7.92% / 0.58% |
LoseSHC / S&P SHC unavailable / 10.77% |
LoseSHC / S&P SHC unavailable / 69.42% |
| 2021-Q20/3 |
LoseSHC / S&P -2.92% / 8.55% |
LoseSHC / S&P SHC unavailable / 6.58% |
LoseSHC / S&P SHC unavailable / 51.81% |
| 2021-Q10/3 |
LoseSHC / S&P -9.04% / 6.17% |
LoseSHC / S&P SHC unavailable / -1.06% |
LoseSHC / S&P SHC unavailable / 7.39% |
| 2020-Q41/3 |
LoseSHC / S&P SHC unavailable / 12.15% |
WinSHC / S&P 5.12% / -3.72% |
LoseSHC / S&P SHC unavailable / -33.42% |
| 2020-Q30/3 |
LoseSHC / S&P SHC unavailable / 8.93% |
LoseSHC / S&P SHC unavailable / -2.04% |
LoseSHC / S&P SHC unavailable / -27.10% |
| 2020-Q20/3 |
LoseSHC / S&P SHC unavailable / 20.54% |
LoseSHC / S&P SHC unavailable / -0.46% |
LoseSHC / S&P SHC unavailable / -27.11% |
| 2020-Q10/3 |
LoseSHC / S&P SHC unavailable / -19.60% |
LoseSHC / S&P SHC unavailable / 3.47% |
LoseSHC / S&P SHC unavailable / -14.75% |
| 2019-Q40/3 |
LoseSHC / S&P SHC unavailable / 9.07% |
LoseSHC / S&P SHC unavailable / 5.36% |
LoseSHC / S&P SHC unavailable / 2.99% |
| 2019-Q30/3 |
LoseSHC / S&P SHC unavailable / 1.70% |
LoseSHC / S&P SHC unavailable / 5.02% |
LoseSHC / S&P SHC unavailable / 0.21% |
| 2019-Q20/3 |
LoseSHC / S&P SHC unavailable / 4.30% |
LoseSHC / S&P SHC unavailable / 6.64% |
LoseSHC / S&P SHC unavailable / 8.65% |
| 2019-Q10/3 |
LoseSHC / S&P SHC unavailable / 13.65% |
LoseSHC / S&P SHC unavailable / 8.12% |
LoseSHC / S&P SHC unavailable / 14.29% |
| 2018-Q40/3 |
LoseSHC / S&P SHC unavailable / -13.52% |
LoseSHC / S&P SHC unavailable / 9.05% |
LoseSHC / S&P SHC unavailable / 18.23% |
| 2018-Q30/3 |
LoseSHC / S&P SHC unavailable / 7.71% |
LoseSHC / S&P SHC unavailable / 10.21% |
LoseSHC / S&P SHC unavailable / 19.06% |
| 2018-Q20/3 |
LoseSHC / S&P SHC unavailable / 3.43% |
LoseSHC / S&P SHC unavailable / 9.03% |
LoseSHC / S&P SHC unavailable / 14.46% |
| 2018-Q10/3 |
LoseSHC / S&P SHC unavailable / -0.76% |
LoseSHC / S&P SHC unavailable / 7.68% |
LoseSHC / S&P SHC unavailable / 12.46% |
| 2017-Q40/3 |
LoseSHC / S&P SHC unavailable / 6.64% |
LoseSHC / S&P SHC unavailable / 7.03% |
LoseSHC / S&P SHC unavailable / 13.82% |
| 2017-Q30/3 |
LoseSHC / S&P SHC unavailable / 4.48% |
LoseSHC / S&P SHC unavailable / 5.68% |
LoseSHC / S&P SHC unavailable / 17.57% |
| 2017-Q20/3 |
LoseSHC / S&P SHC unavailable / 3.09% |
LoseSHC / S&P SHC unavailable / 4.83% |
LoseSHC / S&P SHC unavailable / 17.74% |
| 2017-Q10/3 |
LoseSHC / S&P SHC unavailable / 6.07% |
LoseSHC / S&P SHC unavailable / 3.67% |
LoseSHC / S&P SHC unavailable / 13.32% |
| 2016-Q40/3 |
LoseSHC / S&P SHC unavailable / 3.82% |
LoseSHC / S&P SHC unavailable / 2.09% |
LoseSHC / S&P SHC unavailable / 7.05% |
| 2016-Q30/3 |
LoseSHC / S&P SHC unavailable / 3.85% |
LoseSHC / S&P SHC unavailable / 0.20% |
LoseSHC / S&P SHC unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | SHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 17.84% | 20.78% |
| Annualized return | 17.84% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | SHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -22.62% | 83.14% |
| Annualized return | -5.00% | 12.86% |
10Y · 2020-11-20 to 2026-08-28
| Metric | SHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -23.15% | 319.30% |
| Annualized return | -2.60% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |